RxDoctor Payments Data

Daniel Weed, MD

Radiation Oncology · Indianapolis, INNPI 1194725937

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations.

$964in general payments, 2019–2025

Across 11 payments — averaging $87.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novocure Inc.$188
  • Icotec Medical Inc.$164
  • Boston Scientific$132
  • GSK$125
  • E.r. Squibb & Sons, L.L.C.$124
  • Amgen$121
  • plus $110 from 4 others

What the payments were for

  • Food & beverage$964100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novocure Inc.1$188
Icotec Medical Inc.1$164
Boston Scientific1$132
GSK1$125
E.r. Squibb & Sons, L.L.C.1$124
Amgen1$121
IBA Proton Therapy, Inc.1$44
Tactile Systems Technology Inc2$30
Mevion_medical_systems_inc1$22
Siemens Medical Solutions USA, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$964 in reported general payments places this provider in the 60th percentile of 116 radiation oncology providers in Indiana.

See all radiation oncology providers in Indiana

Medicare billing

Part B allowed, 2024
$260,240
Medicare patients
441
Services billed
3,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl108$816

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →